Skip to content
Campus Alert Archive
SCU

Three Students, One Weekend, and the Fastest Meningitis B Vaccination Drive in California History

CAdisease outbreakadvisorymedium confidence
Confirmed Threat

Three Santa Clara University undergraduates were hospitalized with serogroup B meningococcal disease in a single weekend beginning January 31, 2016, triggering an emergency response led by the Santa Clara County Public Health Department and CDC. All three survived; the first vaccination clinic opened within 48 hours of the second confirmed case, and 4,921 of SCU's 5,232 undergraduates received a first vaccine dose during four clinics held February 4-8, 2016.

Alerts
2
Response
Killed
0
Injured
3
Institution
Santa Clara University
Private Masters · CA
~9,000 studentsSCU Emergency Notification
Confirmed Timeline

Alert Sequence

2 messages in sequence

Some alert texts below are approximate reconstructions from news coverage, not confirmed verbatim transcripts. Reconstructed texts are shown in italic with a dashed border. Verified verbatim texts have a solid border and are marked accordingly.

INITIAL ALERTEmail
Santa Clara University is working with the Santa Clara County Public Health Department regarding confirmed cases of meningococcal disease (meningitis) among three undergraduate students who live on campus. All three students are receiving medical care. Meningococcal disease is caused by bacteria and is not spread through casual contact -- it requires prolonged close contact such as kissing or sharing drinks. Symptoms include sudden fever, severe headache, stiff neck, sensitivity to light, and a rash. If you experience these symptoms, seek immediate medical attention. The university is coordinating with public health officials on next steps, including a vaccination program.

This text has been reconstructed from news coverage and may not reflect the exact original wording.

The initial communication emphasized that meningococcal disease is not spread through casual contact -- a critical public-health message to prevent panic among the broader student body of 9,000.
Three cases within a single weekend at a campus of this size represented a statistically alarming cluster; serogroup B is the most common cause of meningitis in college students and was newly vaccine-preventable as of late 2014.
The phrase 'a vaccination program' referenced an emergency clinic that would open within 48 hours -- one of the fastest large-scale meningitis B vaccination deployments in California history at that point.
UPDATEEmail
Santa Clara University will hold emergency vaccination clinics for meningococcal serogroup B disease (MenB) beginning Thursday, February 4. All 5,232 undergraduate students, as well as graduate students, faculty, and staff at increased risk, are advised to receive the MenB vaccine. Clinics will be held February 4 through February 8 on campus. Two doses are required for full protection; a second clinic series will be scheduled. The vaccine is being provided free of charge. We strongly encourage all eligible members of the SCU community to be vaccinated.

This text has been reconstructed from news coverage and may not reflect the exact original wording.

Four vaccination clinics held February 4-8 vaccinated 4,921 persons -- a 94% coverage rate achieved within one week of the first confirmed case, an exceptionally rapid public health response.
The serogroup B vaccine (Trumenba or Bexsero) had only been FDA-approved in late 2014; the SCU outbreak was one of the first major tests of the vaccine's real-world deployment logistics at a university scale.
Making the vaccine free and available on-campus over multiple days are evidence-based strategies known to maximize uptake in a time-sensitive outbreak setting.
Context

Background

The Santa Clara University meningitis B cluster of January-February 2016 was documented in the CDC's Morbidity and Mortality Weekly Report (MMWR) as a case study in rapid outbreak response. Three undergraduate students became ill on the same weekend -- two with meningitis, one with septicemia (a blood infection) -- all living on campus. The Santa Clara County Public Health Department was notified January 31 and confirmed the outbreak by February 2. Within 48 hours of the second case, SCU and county health officials organized the first emergency vaccination clinic. Over four days (February 4-8, 2016), 4,921 persons received first-dose MenB vaccine, achieving 94% coverage among undergraduates. All three students who became ill were hospitalized and ultimately recovered. No additional cases were identified through May 2016. The outbreak occurred just over a year after the FDA approved the first serogroup B vaccines (Bexsero and Trumenba) in late 2014, making the SCU response one of the earliest large-scale deployments of those vaccines in a campus setting.
Analysis

Key Findings

Three cases in a single weekend triggered a county-coordinated emergency vaccination campaign within 48 hours of the second confirmed case
94% vaccination coverage (4,921 of 5,232 undergraduates) was achieved in just five days, one of the fastest meningitis B vaccination campaigns in California
The outbreak occurred just 14 months after FDA approval of the first serogroup B meningococcal vaccines, making SCU an early real-world test of campus-scale MenB vaccination logistics
All three students survived; no additional cases were identified as of May 2016
Outcome
All three students were hospitalized and recovered. Two had meningitis; one had septicemia. No additional cases were identified as of May 23, 2016. The mass vaccination campaign achieved 94% coverage among eligible persons.
Provenance

Sources

  1. Official
  2. News
  3. Official
  4. Source
Tags
meningitismeningitis-bmeningococcaldisease-outbreakpublic-healthvaccinationcaliforniaprivate-universitycdc-mmwr
Added May 2026Updated May 2026Via ingestion